Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale for the use of clodronate in osteoporosis.
Kanis JA, McCloskey EV, Sirtori P, Khan S, Fern D, Eyres K, Aaron J, Beneton MN. Kanis JA, et al. Among authors: mccloskey ev. Osteoporos Int. 1993;3 Suppl 2:S23-8. doi: 10.1007/BF01623223. Osteoporos Int. 1993. PMID: 8481595 Review.
Clodronate and osteoporosis.
Kanis JA, McCloskey EV, Beneton MN. Kanis JA, et al. Among authors: mccloskey ev. Maturitas. 1996 May;23 Suppl:S81-6. doi: 10.1016/0378-5122(96)01018-3. Maturitas. 1996. PMID: 8865146 Review.
Risk factors in osteoporosis.
Kanis JA, McCloskey EV. Kanis JA, et al. Among authors: mccloskey ev. Maturitas. 1998 Nov 16;30(3):229-33. doi: 10.1016/s0378-5122(98)00090-5. Maturitas. 1998. PMID: 9881321 Review.
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.
Boonen S, Marin F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV; EUROFORS Investigators. Boonen S, et al. Among authors: mccloskey ev. J Clin Endocrinol Metab. 2008 Mar;93(3):852-60. doi: 10.1210/jc.2007-0711. Epub 2007 Dec 26. J Clin Endocrinol Metab. 2008. PMID: 18160462 Clinical Trial.
Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.
Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T; EUROFORS Investigators. Obermayer-Pietsch BM, et al. J Bone Miner Res. 2008 Oct;23(10):1591-600. doi: 10.1359/jbmr.080506. J Bone Miner Res. 2008. PMID: 18505369 Free article. Clinical Trial.
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body JJ, Boyce BF, Calvi LM, Hadji P, McCloskey EV, Saad F, Smith MR, Suva LJ, Taichman RS, Vessella RL, Weilbaecher KN. Coleman RE, et al. Among authors: mccloskey ev. Clin Cancer Res. 2008 Oct 15;14(20):6387-95. doi: 10.1158/1078-0432.CCR-08-1572. Clin Cancer Res. 2008. PMID: 18927277 Free PMC article. Review.
Development and use of FRAX in osteoporosis.
Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F. Kanis JA, et al. Among authors: mccloskey ev. Osteoporos Int. 2010 Jun;21 Suppl 2:S407-13. doi: 10.1007/s00198-010-1253-y. Epub 2010 May 13. Osteoporos Int. 2010. PMID: 20464374 Review.
535 results